SCHEMBL25002964

SCHEMBL25002964

COC(=O)c1cncc(-c2ccc(O)cc2)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.63
CYP11B1 P15538 5/20 0.63
ATM Q13315 1/20 0.56
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA7 P43166 2/20 0.55
CA9 Q16790 2/20 0.55
CA14 Q9ULX7 2/20 0.55
CYP2A6 P11509 1/20 0.54
XDH P47989 4/20 0.50
MKNK1 Q9BUB5 3/20 0.49
MKNK2 Q9HBH9 3/20 0.49
ALDH1A1 P00352 1/20 0.47
S1PR1 P21453 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAP4K4 O95819 1/20 0.47
CYP19A1 P11511 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3715051 0.88 ATM (0.69) CYP11B2CYP11B1ATMCA12CA1
SCHEMBL1179546 0.87 CYP11B1 (0.76) CYP11B2CYP11B1ATMCA12CA1
SCHEMBL2906199 0.86 CYP11B1 (0.62) CYP11B2CYP11B1ATMCYP2A6XDH
SCHEMBL5326283 0.86 CYP11B1 (0.79) CYP11B2CYP11B1ATMCA1CA2
SCHEMBL4592444 0.86 CYP11B1 (0.62) CYP11B2CYP11B1ATMCYP2A6XDH
SCHEMBL9008962 0.85 CYP11B1 (0.61) CYP11B2CYP11B1ATMCYP2A6XDH
SCHEMBL641553 0.84 CYP11B1 (0.60) CYP11B2CYP11B1ATMCYP2A6XDH
SCHEMBL31418026 0.83 CYP11B1 (0.59) CYP11B2CYP11B1ATMCA12CA1
SCHEMBL13188366 0.83 CYP11B1 (0.67) CYP11B2CYP11B1ATMCYP2A6MKNK1
SCHEMBL640445 0.82 CYP11B1 (0.58) CYP11B2CYP11B1ATMCYP2A6XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076347-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 CN disclosed
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 WO disclosed